Terbinafine

Common brands: Terbinafine, Toenail Fungus Treatment, Antifungal, Equate Athletes Foot, Athletes Foot

Top reporter: Aurobindo Pharma Limited

Allylamine Antifungal [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Azole Antifungal [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]
8,649
Total Reports
3,699
Serious Reports
520
Death Reports
30
Reported Reactions
Death Report Ratio: High (6.01%)

Patient Demographics

Male
3,663
Female
3,967

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Terbinafine.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 804
9.6%
2 RASH 483
5.8%
3 PRURITUS 407
4.9%
4 FATIGUE 382
4.6%
5 NAUSEA 374
4.5%
6 PAIN 341
4.1%
7 OFF LABEL USE 328
3.9%
8 AGEUSIA 321
3.8%
9 HEADACHE 295
3.5%
10 DIARRHOEA 285
3.4%
11 DYSPNOEA 263
3.1%
12 DRUG INTERACTION 258
3.1%
13 MALAISE 255
3.0%
14 ANXIETY 247
2.9%
15 DIZZINESS 237
2.8%
16 CHRONIC KIDNEY DISEASE 231
2.8%
17 ACUTE KIDNEY INJURY 226
2.7%
18 ARTHRALGIA 224
2.7%
19 CONDITION AGGRAVATED 224
2.7%
20 PRODUCT USE IN UNAPPROVED INDICATION 222
2.7%
21 WEIGHT DECREASED 220
2.6%
22 DYSGEUSIA 218
2.6%
23 DEPRESSION 214
2.6%
24 DRUG RESISTANCE 204
2.4%
25 URTICARIA 201
2.4%
26 DECREASED APPETITE 198
2.4%
27 PYREXIA 194
2.3%
28 ERYTHEMA 180
2.1%
29 RENAL FAILURE 178
2.1%
30 TREATMENT FAILURE 162
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.